Literature DB >> 1846385

Expression of VHIII-associated cross-reactive idiotype on human B lymphocytes. Association with staphylococcal protein A binding and Staphylococcus aureus Cowan I stimulation.

F Shokri1, R A Mageed, B R Maziak, R Jefferis.   

Abstract

It has been demonstrated that staphylococcal protein A (SPA) has an "alternative" binding site with specificity for human Ig H chain V region of the VHIII subgroup. Because the major mitogenic component of Staphylococcus aureus Cowan I (SAC) is SPA, it is possible that SAC stimulates a subpopulation of B cells expressing Ig of the VHIII H chain subgroup. In the present study, we have investigated further the relationship between SPA binding and the expression of VHI- or VHIII-associated cross-reactive idiotype (CRI) on the surface of tonsillar B lymphocytes enriched for the expression or nonexpression of the CRI, and we examined the Ig secreted by cell lines established from these populations of B cells by EBV transformation. The VHIII CRI (D12)-enriched population yielded 21 cell lines, with 67% of them secreting SPA-reactive Ig; in contrast, only 6% (1 of 16) of VHI CRI-expressing lines secreted SPA-reactive Ig. The CRI-negative B cell population yielded 54 cell lines, of which 20% secreted SPA-reactive Ig, as might be anticipated because a majority of VHIII Ig+ B cells will be CRI-. SAC stimulation of CRI+ and CRI- populations showed preferential stimulation of the D12 population. These data support the proposal that SAC stimulation of human B cells is mediated through binding of SPA by its alternative binding site to IgV regions of the VHIII subgroup.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846385

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Rheumatoid factors in primary Sjögren's syndrome (pSS) use diverse VH region genes, the majority of which show no evidence of somatic hypermutation.

Authors:  K E Elagib; M Børretzen; R Jonsson; H J Haga; J Thoen; K M Thompson; J B Natvig
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

Review 2.  Human B lymphocytes mature.

Authors:  J Gordon
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

3.  Characterization of ABF-1, a novel basic helix-loop-helix transcription factor expressed in activated B lymphocytes.

Authors:  M E Massari; R R Rivera; J R Voland; M W Quong; T M Breit; J J van Dongen; O de Smit; C Murre
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

4.  Novel unconventional binding site in the variable region of immunoglobulins.

Authors:  K Rajagopalan; G Pavlinkova; S Levy; P R Pokkuluri; M Schiffer; B E Haley; H Kohler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

5.  Increased IgA rheumatoid factor and V(H)1 associated cross reactive idiotype expression in patients with Lyme arthritis and neuroborreliosis.

Authors:  J S Axford; D H Rees; R A Mageed; P Wordsworth; A Alavi; A C Steere
Journal:  Ann Rheum Dis       Date:  1999-12       Impact factor: 19.103

6.  Two novel cationic staphylococcal proteins induce IL-2 secretion, proliferation and immunoglobulin synthesis in peripheral blood mononuclear cells (PBMC) of both healthy controls and patients with common variable immunodeficiency (CVID).

Authors:  A Jahreis; Y Yousif; J A Rump; R Dräger; A Vogt; H H Peter; M Schlesier
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

Review 7.  Revenge of the microbes. Superantigens of the T and B cell lineage.

Authors:  L Goodglick; J Braun
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

8.  Sequence analysis of immunoglobulin heavy-chain variable region genes from the synovium of a rheumatoid arthritis patient shows little evidence of mutation but diverse CDR3.

Authors:  C M Brown; K J Fitzgerald; S P Moyes; R A Mageed; D G Williams; R N Maini
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

9.  Immunoglobulin heavy chain variable region gene utilization by B cell hybridomas derived from rheumatoid synovial tissue.

Authors:  C M Brown; C Longhurst; G Haynes; C Plater-Zyberk; A Malcolm; R N Maini
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

10.  Repertoire of CD5+ and CD5- cord blood B cells: specificity and expression of VH I and VH III associated idiotopes.

Authors:  L E Mackenzie; R A Mageed; P Y Youinou; B Yuksel; R Jefferis; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.